Abbott Laboratories ROE - Return on Equity 2010-2024 | ABT

Abbott Laboratories return on equity for the quarter ending September 30, 2024 was 14.65.

  • Abbott Laboratories average return on equity for 2023 was 14.7, a 32.38% decline from 2022.
  • Abbott Laboratories average return on equity for 2022 was 21.74, a 10.36% decline from 2021.
  • Abbott Laboratories average return on equity for 2021 was 19.7, a 69.24% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Abbott Laboratories ROE - Return on Equity 2010-2024 | ABT

  • Abbott Laboratories average return on equity for 2023 was 14.7, a 32.38% decline from 2022.
  • Abbott Laboratories average return on equity for 2022 was 21.74, a 10.36% decline from 2021.
  • Abbott Laboratories average return on equity for 2021 was 19.7, a 69.24% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.